TRICHODYSPLASIA SPINULOSA

TRICHODYSPLASIA SPINULOSA was reported 381 times

TRICHODYSPLASIA SPINULOSA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 41 0.0019
1 CCR5 Co-receptor Antagonist [EPC] 4 0.0017
2 Selective T Cell Costimulation Blocker [EPC] 6 0.0013
3 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 17 0.0008
4 alpha-Hydroxy Acid [EPC] 1 0.0005
5 CD52-directed Cytolytic Antibody [EPC] 6 0.0003
6 Purine Antimetabolite [EPC] 30 0.0003
7 Hedgehog Pathway Inhibitor [EPC] 2 0.0002
8 Corticosteroid [EPC] 256 0.0002
9 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0002
10 Protease Inhibitor [EPC] 4 0.0001
11 Interleukin-6 Receptor Antagonist [EPC] 12 0.0001
12 CD20-directed Cytolytic Antibody [EPC] 27 0.0001
13 Alkylating Drug [EPC] 19 0.0001
14 Nitroimidazole Antimicrobial [EPC] 5 0.0001
15 Antirheumatic Agent [EPC] 8 0.0001
16 Kinase Inhibitor [EPC] 39 0.0001
17 Aminoglycoside Antibacterial [EPC] 3 0.0001
18 Cytochrome P450 3A Inhibitor [EPC] 4 0.0001
19 Calcineurin Inhibitor Immunosuppressant [EPC] 8 0.0001
20 Tetracycline-class Drug [EPC] 4 0.0001
21 Janus Kinase Inhibitor [EPC] 9 0.0001
22 Folate Analog Metabolic Inhibitor [EPC] 22 0.0000
23 Retinoid [EPC] 8 0.0000
24 Dihydropyridine Calcium Channel Blocker [EPC] 9 0.0000
25 Azole Antifungal [EPC] 2 0.0000
26 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
27 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
28 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
29 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 2 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000